Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia.
Rapaport J, Sadgrove NJ, Arruda S, Swearingen A, Abidi Z, Sadick N.
Rapaport J, et al. Among authors: arruda s.
J Drugs Dermatol. 2023 Jun 1;22(6):559-564. doi: 10.36849/JDD.7403.
J Drugs Dermatol. 2023.
PMID: 37276165
Here, we present a novel topical serum, REVIVV®, that contains a proprietary blend of phytochemicals designed to stimulate hair growth, reduce shedding, and restore homeostasis to the hair follicle. The serum’s safety and efficacy were assessed in 150 par …
Here, we present a novel topical serum, REVIVV®, that contains a proprietary blend of phytochemicals designed to stimulate hair grow …